Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review

Front Immunol. 2023 Sep 22:14:1240089. doi: 10.3389/fimmu.2023.1240089. eCollection 2023.

Abstract

Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.

Keywords: COVID-19; IVIG (intravenous immunoglobulin) administration; autoimmune encephalitis; diagnosis; high-dose steroid therapy.

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases of the Nervous System* / drug therapy
  • COVID-19* / complications
  • Encephalitis, Viral* / drug therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Steroids / therapeutic use

Substances

  • Immunoglobulins, Intravenous
  • Steroids

Supplementary concepts

  • Hashimoto's encephalitis

Grants and funding

This work was funded by the Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou and Chang Gung Research-Database. (Project No.: CGRPG3M0021 and CGRPG3M0041).